NCT06028997

Brief Summary

Sleep plays a fundamental role in both mental- and physical-health, with good sleep health including adequate duration and quality, appropriate timing, regularity, and absence of sleep disorders. The purpose of this study is to evaluate sleep in adolescent and if brief behavioral and sleep hygiene education with mindfulness intervention improves, sleep timing, sleep duration, sleep quality, anxiety- and depression symptoms. During adolescence extensive physiological changes happen that make it easier for adolescents to stay up later, that may increase the time it may take them to fall-asleep and developing insomnia symptoms. At the same time psychosocial changes happen, the societal changes in the last decade may even have further amplified late sleep in adolescents, with increase in social media use and evening screen-time. As sleep need is not decreased and with adolescents having to wake up at "socially acceptable times" rather than the endogenous sleep offset time, sleep duration may be shortened causing chronic sleep loss and daytime sleepiness. Insufficient sleep in adolescents may affect their daytime functioning, causing fatigue and memory issues, affect school attendance and academic performance, affect mood, mental- and physical health, cause behavioral dysfunction and has been associated with worse health outcomes, adverse risk behaviors and even increase risk for accidents.This study should advance understanding of sleep in adolescents and if this simple interventions can be effective in improving their sleep and mental health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 28, 2023

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

August 29, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 8, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 19, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 19, 2024

Completed
Last Updated

July 30, 2024

Status Verified

July 1, 2024

Enrollment Period

10 months

First QC Date

August 29, 2023

Last Update Submit

July 29, 2024

Conditions

Keywords

sleep regularitysleep durationadolescentsbehavioral therapysleep hygiene educationmindfulness intervention

Outcome Measures

Primary Outcomes (5)

  • Chronotype and relationship with sleep duration, anxiety- and depression symptoms

    Chronotype evaluated with validated sleep questionnaire the Morningness-Eveningness Questionnaire (MEQ), a nineteen-item questionnaire to assess the preferred timing of sleep and activity (outcome presented on scale of 31-86 points) to identify early-, intermediate- and evening chronotypes and evaluate if the different chronotype-groups differ in sleep duration (evaluated in hours and minutes)

    Baseline and week 9

  • Chronotype and relationship with anxiety symptoms

    Chronotype evaluated with validated sleep questionnaire the Morningness-Eveningness Questionnaire (MEQ), a nineteen-item questionnaire to assess the preferred timing of sleep and activity (outcome presented on scale of 31-86 points) to identify early-, intermediate- and evening chronotypes and evaluate if they differ in anxiety symptoms when evaluated with the general anxiety disorder scale-7 (GAD-7), a seven item validated questionnaire designed to screen for and access severity of anxiety (based on scores from 0-21)

    Baseline and week 9

  • Chronotype and relationship with depression symptoms

    Chronotype evaluated with validated sleep questionnaire the Morningness-Eveningness Questionnaire (MEQ), a nineteen-item questionnaire to assess the preferred timing of sleep and activity (outcome presented on scale of 31-86 points) to identify early-, intermediate- and evening chronotypes and evaluate if they differ in depression symptoms when evaluated with the patient health questionnaire (PHQ-9), a nine-item validated questionnaire (scores from 0-27), with higher scores indicating more symptoms

    Baseline and week 9

  • Chronotype and relationship with depression symptoms

    Chronotype evaluated with validated sleep questionnaire the Morningness-Eveningness Questionnaire (MEQ), a nineteen-item questionnaire to assess the preferred timing of sleep and activity (outcome presented on scale of 31-86 points) to identify early-, intermediate- and evening chronotypes and evaluate if they differ in depression symptoms when evaluated with the Becks depression inventory (BDI-II) a ten-item questionnaires to screen for and access severity of depression (scores from 0-63) symptoms, with higher scores indicating more symptoms

    Baseline and week 9

  • Change in sleep regularity and social jetlag from baseline to follow up after 8-weeks of intervention

    Sleep duration, sleep onset and sleep conclusions (all measured in hours and minutes) to calculate sleep midpoint on school- and free days, to calculate social jetlag (in hours and minutes)

    Baseline and week 9

Study Arms (1)

Intervention arm

EXPERIMENTAL
Behavioral: Behavioral and Sleep Hygiene Education with Mindfulness Intervention

Interventions

Education about good sleep hygiene practices and behavior advice to improve sleep based on current literature for 10-15 minutes/week followed by 50 minutes of yoga Nidra and breathing excersices

Intervention arm

Eligibility Criteria

Age15 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • First year student attending a junior collage in Northern Europe (Akureyri Iceland)

You may not qualify if:

  • chronic atrial fibrillation or ventricular trigemini,
  • severe uncontrolled asthma or other pulmonary diseases,
  • moderate and severe obstructive sleep apnea (OSA)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Menntaskolinn a Akureyri

Akureyri, 600, Iceland

Location

Sjukrahusid a Akureyri

Akureyri, 600, Iceland

Location

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Officials

  • Solveig Magnusdottir, MD, MSc, MBA

    MyCardio SleepImage

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Prospective cohort-study
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chief Medical Officer

Study Record Dates

First Submitted

August 29, 2023

First Posted

September 8, 2023

Study Start

August 28, 2023

Primary Completion

June 19, 2024

Study Completion

June 19, 2024

Last Updated

July 30, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

IPD will not be shared

Locations